Can vaccine legacy explain the British pertussis resurgence?
about
The pertussis enigma: reconciling epidemiology, immunology and evolutionRoads to the development of improved pertussis vaccines paved by immunologyPertussis models to inform vaccine policyPertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.Dynamics of Pertussis Transmission in the United States.Maternal pertussis immunisation: clinical gains and epidemiological legacy.Combating pertussis resurgence: One booster vaccination schedule does not fit allA change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.Asymptomatic transmission and the resurgence of Bordetella pertussis.Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.Forecasting Epidemiological Consequences of Maternal Immunization.Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.Anticipating the emergence of infectious diseases.Epidemiological evidence for herd immunity induced by acellular pertussis vaccinesCore pertussis transmission groups in England and Wales: A tale of two eras.The impact of past vaccination coverage and immunity on pertussis resurgence.Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.
P2860
Q26772095-FA7C0745-4AA7-483D-9FF9-F69011B420AEQ26782939-ECFBC8AC-78DD-4CA2-BFEF-E1BA4FB33E3CQ27014700-0ECD8A5A-2625-418E-B463-617CB915B455Q27302088-B997C8FF-C488-4AA0-B5EE-87C57CF1411EQ30358245-0A3356CB-6446-42B4-BCE9-8C8D23025574Q33813965-7FBF5190-F178-4F61-A010-AFC81D7C8E09Q35062572-8D8B8624-1E2F-4EB3-BA18-753E6B283030Q35533082-A35D60A3-2152-4D9A-BF80-03BD9860B455Q35672136-A3B6E20E-7DA4-4597-8399-1C7C1BF7A861Q36143574-58A705D4-A9C9-49C0-8FFE-D75A7D76BB91Q37410327-D7373732-622D-43AE-8AE6-562B852DF7ACQ38626455-6F4593B1-CEB3-4EA9-982B-0E2D1C0DFEC4Q38692361-E9221011-38B1-4588-BA3A-EF23841ADDC0Q42432459-2C77C49C-9E59-4E64-AD87-DC837B0A78B0Q50067166-AF88D056-3AE2-4DF6-8D42-3835E1558832Q51144168-AE77330F-7DE9-4A0D-850F-95AD89D14036Q51828856-812F4F1F-82C9-4D4F-A410-76A640104329Q55294745-BDEAE45E-92A2-4786-B019-CD2B9486BF40
P2860
Can vaccine legacy explain the British pertussis resurgence?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Can vaccine legacy explain the British pertussis resurgence?
@en
Can vaccine legacy explain the British pertussis resurgence?
@nl
type
label
Can vaccine legacy explain the British pertussis resurgence?
@en
Can vaccine legacy explain the British pertussis resurgence?
@nl
prefLabel
Can vaccine legacy explain the British pertussis resurgence?
@en
Can vaccine legacy explain the British pertussis resurgence?
@nl
P2860
P1433
P1476
Can vaccine legacy explain the British pertussis resurgence?
@en
P2093
Maria A Riolo
Pejman Rohani
P2860
P304
P356
10.1016/J.VACCINE.2013.09.020
P407
P577
2013-10-16T00:00:00Z